Rothwell Investment Advisors, LLC’s Collegium Pharmaceutical COLL Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$720	Buy	+33	New	+$963	﹤0.01%	1082

Other funds holding COLL

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Ballast Asset Management Dallas, Texas $230M AUM 34.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Rothwell Investment Advisors, LLC's COLL Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 33 shares worth $720. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings.

90 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

Rothwell Investment Advisors, LLC held 33 shares of Collegium Pharmaceutical worth $720 as of Q3 2026.
Collegium Pharmaceutical was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Collegium Pharmaceutical made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1082 holding.
90 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.